Research Solutions (RSSS) 10-Q 14 Feb 18 2018 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Dec. 31, 2017	Feb. 12, 2018
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q2
Entity Registrant Name	Research Solutions, Inc.
Entity Central Index Key	1,386,301
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Trading Symbol	RSSS
Entity Common Stock, Shares Outstanding		24,147,582

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Jun. 30, 2017
Current assets:
Cash and cash equivalents	$ 4,924,620	$ 5,773,950
Accounts receivable, net of allowance of $119,462 and $119,536, respectively	3,739,099	5,465,299
Prepaid expenses and other current assets	315,906	196,820
Prepaid royalties	736,145	566,282
Total current assets	9,715,770	12,002,351
Other assets:
Property and equipment, net of accumulated depreciation of $728,271 and $699,421, respectively	81,340	85,737
Intangible assets, net of accumulated amortization of $679,836 and $623,714, respectively	0	41,870
Deposits and other assets	14,383	14,466
Right of use asset, net of accumulated amortization of $99,864 and $45,105, respectively	363,158	417,917
Total assets	10,174,651	12,562,341
Current liabilities:
Accounts payable and accrued expenses	5,053,770	6,443,056
Deferred revenue	1,306,429	1,335,475
Lease liability, current portion	115,263	110,888
Total current liabilities	6,475,462	7,889,419
Long-term liabilities:
Lease liability, long-term portion	269,924	328,299
Total liabilities	6,745,386	8,217,718
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 24,147,582 and 23,883,145 shares issued and outstanding, respectively	24,148	23,883
Additional paid-in capital	22,764,915	22,267,327
Accumulated deficit	(19,273,403)	(17,875,858)
Accumulated other comprehensive loss	(86,395)	(70,729)
Total stockholders’ equity	3,429,265	4,344,623
Total liabilities and stockholders’ equity	$ 10,174,651	$ 12,562,341

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets [Parenthetical] - USD ($)	Dec. 31, 2017	Jun. 30, 2017
Allowance for Doubtful Accounts Receivable, Current	$ 119,462	$ 119,536
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	728,271	699,421
Finite-Lived Intangible Assets, Accumulated Amortization	$ 679,836	$ 623,714
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	24,147,582	23,883,145
Common Stock, Shares, Outstanding	24,147,582	23,883,145
Use Rights [Member]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 99,864	$ 45,105

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Revenue:
Total revenue	$ 6,823,220	$ 6,085,699	$ 13,571,060	$ 12,264,170
Cost of revenue:
Total cost of revenue	5,087,350	4,710,313	10,085,751	9,455,276
Gross profit	1,735,870	1,375,386	3,485,309	2,808,894
Operating expenses:
Selling, general and administrative	2,391,969	2,401,633	4,929,005	4,299,332
Depreciation and amortization	46,330	32,426	86,898	62,895
Total operating expenses	2,438,299	2,434,059	5,015,903	4,362,227
Loss from operations	(702,429)	(1,058,673)	(1,530,594)	(1,553,333)
Other income (expenses):
Interest expense	(3,000)	(3,000)	(6,000)	(6,000)
Other income	11,312	5,424	24,114	10,134
Total other income	8,312	2,424	18,114	4,134
Loss from operations before provision for income taxes	(694,117)	(1,056,249)	(1,512,480)	(1,549,199)
Provision for income taxes	(9,816)	(9,337)	(21,567)	(22,942)
Loss from continuing operations	(703,933)	(1,065,586)	(1,534,047)	(1,572,141)
Discontinued operations:
Income from discontinued operations	0	222,626	0	318,515
Gain from sale of discontinued operations	79,353	0	136,502	0
Income from discontinued operations	79,353	222,626	136,502	318,515
Net loss	(624,580)	(842,960)	(1,397,545)	(1,253,626)
Other comprehensive income (loss):
Foreign currency translation	(6,715)	5,195	(15,666)	1,912
Comprehensive loss	$ (631,295)	$ (837,765)	$ (1,413,211)	$ (1,251,714)
Loss per common share:
Loss per share from continuing operations, basic and diluted	$ (0.03)	$ (0.05)	$ (0.07)	$ (0.06)
Income per share from discontinued operations, basic and diluted	0	0.01	0.01	0.01
Net loss per share, basic and diluted	$ (0.03)	$ (0.04)	$ (0.06)	$ (0.05)
Weighted average common shares outstanding, basic and diluted	23,455,654	23,200,975	23,418,046	23,166,272
Platforms [Member]
Revenue:
Total revenue	$ 413,404	$ 219,137	$ 801,349	$ 391,209
Cost of revenue:
Total cost of revenue	90,362	45,623	174,349	75,587
Transactions [Member]
Revenue:
Total revenue	6,409,816	5,866,562	12,769,711	11,872,961
Cost of revenue:
Total cost of revenue	$ 4,996,988	$ 4,664,690	$ 9,911,402	$ 9,379,689

Condensed Consolidated Stateme5

Condensed Consolidated Statement of Stockholders' Equity - 6 months ended Dec. 31, 2017 - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Other Comprehensive Loss [Member]
Balance at Jun. 30, 2017	$ 4,344,623	$ 23,883	$ 22,267,327	$ (17,875,858)	$ (70,729)
Balance (in shares) at Jun. 30, 2017		23,883,145
Fair value of vested stock options	389,236	$ 0	389,236	0	0
Fair value of vested restricted common stock	205,339	$ 339	205,000	0	0
Fair value of vested restricted common stock (in shares)		338,302
Repurchase of common stock	$ (102,955)	$ (87)	(102,868)	0	0
Repurchase of common stock (in shares)	(87,100)	(87,100)
Modification cost of stock options	$ 6,233	$ 0	6,233	0	0
Common stock issued upon exercise of stock options	$ 0	$ 13	(13)	0	0
Common stock issued upon exercise of stock options (in shares)	175,000	13,235
Net loss for the period	$ (1,397,545)	$ 0	0	(1,397,545)	0
Foreign currency translation	(15,666)	0	0	0	(15,666)
Balance at Dec. 31, 2017	$ 3,429,265	$ 24,148	$ 22,764,915	$ (19,273,403)	$ (86,395)
Balance (in shares) at Dec. 31, 2017		24,147,582

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flow from operating activities:
Net loss	$ (1,397,545)	$ (1,253,626)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities of operations:
Gain from sale of discontinued operations	(136,502)	0
Depreciation and amortization	86,898	62,895
Amortization of lease right	54,759	0
Fair value of vested stock options	389,236	228,491
Fair value of vested restricted common stock	205,339	177,194
Modification cost of stock options	6,233	0
Changes in operating assets and liabilities:
Accounts receivable	1,726,200	696,302
Prepaid expenses and other current assets	17,416	(56,140)
Prepaid royalties	(169,863)	(1,044,250)
Deposits and other assets	0	(11,374)
Accounts payable and accrued expenses	(1,389,286)	1,449,375
Deferred revenue	(29,046)	527,695
Lease liability	(54,000)	0
Net cash provided by (used in) operating activities	(690,161)	776,562
Cash flow from investing activities:
Purchase of property and equipment	(29,284)	(16,091)
Purchase of intangible assets	(14,252)	(9,751)
Net cash used in investing activities	(43,536)	(25,842)
Cash flow from financing activities:
Common stock repurchase and retirement	(102,955)	(82,354)
Net cash used in financing activities	(102,955)	(82,354)
Effect of exchange rate changes	(12,678)	3,386
Net increase (decrease) in cash and cash equivalents	(849,330)	671,752
Cash and cash equivalents, beginning of period	5,773,950	6,076,875
Cash and cash equivalents, end of period	4,924,620	6,748,627
Supplemental disclosures of cash flow information:
Cash paid for income taxes	21,567	22,942
Cash paid for interest	$ 6,000	$ 6,000

Organization, Nature of Busines

Organization, Nature of Business and Basis of Presentation	6 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Nature of Business and Basis of Presentation	Note 1. Organization, Nature of Business and Basis of Presentation Organization Research Solutions, Inc. (the “Company,” “Research Solutions,” “we,” “us” or “our”) was incorporated in the State of Nevada on November 2, 2006, and is a publicly traded holding company with two wholly owned subsidiaries: Reprints Desk, Inc., a Delaware corporation and Reprints Desk Latin America S. de R.L. de C.V, an entity organized under the laws of Mexico. Nature of Business We provide two service offerings to our customers: annual licenses that allow customers to access and utilize certain premium features of our cloud based software-as-a-service (“SaaS”) research intelligence platform (“Platforms”) and the transactional sale of published scientific, technical, and medical (“STM”) content managed, sourced and delivered through the Platform (“Transactions”). Platforms and Transactions are packaged as a single solution that enable life science and other research-intensive organizations to speed up research and development activities with faster, single sourced access and management of content and data used throughout the intellectual property development lifecycle. Platforms Our cloud-based SaaS research intelligence platform consists of proprietary software and Internet-based interfaces. Legacy functionality allows customers to initiate orders, route orders for the lowest cost acquisition, manage transactions, obtain spend and usage reporting, automate authentication, and connect seamlessly to in-house and third-party software systems. Customers can also enhance the information resources they already own or license and collaborate around bibliographic information. Additional functionality has recently been added to our Platform in the form of interactive app-like gadgets. An alternative to manual data filtering, identification and extraction, gadgets are designed to gather, augment, and extract data across a variety of formats, including bibliographic citations, tables of contents, RSS feeds, PDF files, XML feeds, and web content. We are rapidly developing new gadgets in order to build an ecosystem of gadgets. Together, these gadgets will provide researchers with an “all in one” toolkit, delivering efficiencies in core research workflows and knowledge creation processes. Our Platform is deployed as a single, multi-tenant system across our entire customer base. Customers securely access the Platform through online web interfaces and via web service APIs that enable customers to leverage Platform features and functionality from within in-house and third-party software systems. The Platform can also be configured to satisfy a customer’s individual preferences. We leverage our Platform’s efficiencies in scalability, stability and development costs to fuel rapid innovation and competitive advantage. Transactions Researchers and knowledge workers in life science and other research-intensive organizations generally require single copies of published STM journal articles for use in their research activities. These individuals are our primary users. Our Platform provides our customers with a single source to the universe of published STM content that includes over 70 million existing STM articles and over one million newly published STM articles each year. Our Platform allows customers to find and download digital versions of STM articles that are critical to their research. Customers submit orders for the articles they need which we source and electronically deliver to them generally in under an hour. We also obtain the necessary permission licenses from the content publisher or other rights holder so that our customer’s use complies with applicable copyright laws. We have arrangements with hundreds of content publishers that allow us to distribute their content. The majority of these publishers provide us with electronic access to their content, which allows us to electronically deliver single articles to our customers often in a matter of minutes. Principles of Consolidation The accompanying financial statements are consolidated and include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Basis of Presentation The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017 filed with the SEC. The condensed consolidated balance sheet as of June 30, 2017 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded intangibles, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services, and realization of deferred tax assets. Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $ 250,000 Cash denominated in Euros with a US Dollar equivalent of $ 63,669 93,359 The Company has no customers that represent 10 The Company has no customers that accounted for greater than 10 Three Months Ended Six Months Ended 2017 2016 2017 2016 Vendor A 15 % 18 % 15 % 18 % Vendor B 12 % * 12 % * Vendor C 12 % * 12 % * * Less than 10% The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing two service offerings to our customers: annual licenses that allow customers to access and utilize certain premium features of our cloud based SaaS research intelligence platform (Platforms) and the transaction sale of STM content managed, sourced and delivered through the Platform (Transactions). Platforms We charge a subscription fee that allows customers to access and utilize certain premium features of our Platform. Revenue is recognized ratably over the term of the subscription agreement, which is typically one year, provided all other revenue recognition criteria have been met. Billings or payments received in advance of revenue recognition are recorded as deferred revenue. Transactions We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured. Customer deposits and billings or payments received in advance of revenue recognition are recorded as deferred revenue. Platforms Cost of Platform revenue consists primarily of personnel costs of our operations team, and to a lesser extent managed hosting providers and other third-party service and data providers. Transactions Cost of Transaction revenue consists primarily of the respective copyright fee for the permitted use of the content, less a discount in most cases, and to a much lesser extent, personnel costs of our operations team and third-party service providers. The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (FASB) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates. The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to a gain of $ 485 12,872 63,669 93,359 Six Months Ended Year Ended 2017 2016 2017 2016 Period end Euro : US Dollar exchange rate 1.20 1.09 1.09 1.11 Average period Euro : US Dollar exchange rate 1.17 1.11 1.09 1.11 Period end Mexican Peso : US Dollar exchange rate 0.05 0.05 0.05 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05 0.05 0.06 Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At December 31, 2017 potentially dilutive securities include options to acquire 3,185,435 1,985,000 3,122,277 1,985,000 Basic and diluted net loss per common share is the same for the three and six months ended December 31, 2017 and 2016 because all stock options, warrants, and unvested restricted common stock are anti-dilutive. In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Line of Credit

Line of Credit	6 Months Ended
	Dec. 31, 2017
Line of Credit Facility [Abstract]
Line of Credit	Note 3. Line of Credit The Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) on July 23, 2010, which, as amended, provides for a revolving line of credit for the lesser of $ 2,500,000 80 Financial covenants include maintaining an adjusted quick ratio of unrestricted cash and net accounts receivable, divided by current liabilities plus debt less deferred revenue of at least 1.15 to 1.0, and maintaining tangible net worth of $1,500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2017, plus 50% of the dollar value of equity issuances after October 1, 2017 and the principal amount of subordinated debt. 2.25 1.3 1.0 the prime rate plus 5.25% 6.75 There were no outstanding borrowings under the line as of December 31, 2017 and June 30, 2017, respectively. As of December 31, 2017, there was approximately $ 2,490,000

Lease Obligations

Lease Obligations	6 Months Ended
	Dec. 31, 2017
Leases [Abstract]
Lease Obligations	Note 4. Lease Obligations During the period ended March 31, 2017, the Company entered into a 48 month non-cancellable lease for its office facilities that will require monthly payments ranging from $10,350 to $11,475 through January 2021. In accounting for the lease, the Company adopted ASU 2016-02, Leases which requires a lessee to record a right-of-use asset and a corresponding lease liability at the inception of the lease initially measured at the present value of the lease payments. The Company classified the lease as an operating lease and determined that the fair value of the lease liability at the inception of the lease was $463,000 using a discount rate of 3.75%. During the six months ended December 31, 2017, the Company made payments of $54,000 towards the lease liability. As of December 31, 2017 and June 30, 2017, lease liability amounted to $385,187 and $439,187, respectively. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. Rent expense, including real estate taxes, for the six months ended December 31, 2017 and 2016 was $ 62,881 32,564 54,759

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Dec. 31, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 5. Stockholders’ Equity Stock Options In December 2007, we established the 2007 Equity Compensation Plan (the “2007 Plan”) and in November 2017 we established the 2017 Omnibus Incentive Plan (the “2017 Plan”), collectively (the “Plans”). The Plans were approved by our board of directors and stockholders. The purpose of the Plans is to grant stock and options to purchase our common stock, and other incentive awards, to our employees, directors and key consultants. On November 10, 2016, the maximum number of shares of common stock that may be issued pursuant to awards granted under the 2007 Plan increased from 5,000,000 7,000,000 1,874,513 1,592,130 The majority of awards issued under the Plans vest immediately or over three years, with a one year cliff vesting period, and have a term of ten years. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period. All Options Vested Options Unvested Options Shares Weighted Shares Weighted Shares Weighted Outstanding at June 30, 2017 3,130,310 1.15 2,994,851 1.15 135,459 1.07 Granted 707,000 1.31 685,000 1.31 22,000 1.20 Options vesting - - 48,250 1.06 (48,250) 1.06 Exercised (175,000) 1.10 (175,000) 1.10 - - Forfeited/Cancelled (476,875) 1.31 (471,042) 1.32 (5,833) 1.09 Outstanding at December 31, 2017 3,185,435 $ 1.16 3,082,059 $ 1.16 103,376 $ 1.07 Six Months Ended 2017 2016 Expected dividend yield 0 % 0 % Risk-free interest rate 1.45% - 2.23 % 1.27% - 1.76 % Expected life (in years) 2.60 - 6.0 5 - 6 Expected volatility 75% - 76 % 79.2% - 81.4 % The weighted average remaining contractual life of all options outstanding as of December 31, 2017 was 6.04 5.98 434,042 421,343 During the six months ended December 31, 2017, the Company granted 707,000 383,890 389,236 13,235 175,000 17,600 6,233 As of December 31, 2017, the amount of unvested compensation related to stock options was $ 68,175 Option Options Remaining Options $ 0.59 8,150 4.50 8,150 0.60 5,000 4.50 5,000 0.65 6,150 4.50 6,150 0.70 225,000 7.93 225,000 0.77 59,500 5.76 59,500 0.80 16,000 7.64 16,000 0.90 25,667 6.31 25,667 0.97 6,000 4.50 6,000 1.00 300,249 2.60 300,247 1.02 247,000 2.90 247,000 1.05 457,529 8.63 415,530 1.07 53,898 4.79 53,898 1.09 156,165 7.95 116,790 1.10 105,000 7.50 105,000 1.14 3,674 4.50 3,674 1.15 293,000 3.07 293,000 1.20 353,414 9.57 331,414 1.25 32,000 5.12 32,000 1.30 263,000 4.18 263,000 1.50 380,000 1.00 380,000 1.75 1,067 4.50 1,067 1.80 162,550 5.45 162,550 1.85 24,000 5.09 24,000 1.97 1,422 4.50 1,422 Total 3,185,435 3,082,059 Warrants Number of Weighted Outstanding, June 30, 2017 1,985,000 1.25 Granted - - Exercised - - Expired/Cancelled - - Outstanding, December 31, 2017 1,985,000 $ 1.25 Exercisable, June 30, 2017 1,985,000 $ 1.25 Exercisable, December 31, 2017 1,985,000 $ 1.25 There was no intrinsic value for all warrants outstanding as of December 31, 2017, based on the fair value of the Company’s common stock on December 31, 2017. Warrant Warrants Remaining Warrants $ 1.19 100,000 3.98 100,000 1.25 1,885,000 3.45 1,885,000 Total 1,985,000 1,985,000 Restricted Common Stock Prior to July 1, 2017, the Company issued 1,573,197 1,563,074 1,150,136 During the six months ended December 31, 2017, the Company issued an additional 338,302 354,366 1.02 1.20 The total fair value of restricted common stock vesting during the six months ended December 31, 2017 was $ 205,339 561,965 Number of Fair Value Weighted Non-vested, June 30, 2017 513,194 412,938 0.92 Granted 338,302 354,366 1.05 Vested (193,336) (205,339) 0.90 Forfeited - - - Non-vested, December 31, 2017 658,160 $ 561,965 $ 0.99 Common Stock Repurchase and Retirement During the six months ended December 31, 2017, the Company repurchased 87,100 1.18 102,955

Gain from Sale of Discontinued

Gain from Sale of Discontinued Operations (Reprints and ePrints business line)	6 Months Ended
	Dec. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]
Gain from Sale of Discontinued Operations (Reprints and ePrints business line)	Note 6. Gain from Sale of Discontinued Operations (Reprints and ePrints business line) On June 30, 2017, we sold the intangible assets of our Reprints and ePrints business pursuant to an Asset Purchase Agreement dated June 20, 2017. The aggregate net consideration for the sale included earn-out payments of 45 136,502

Summary of Significant Accoun13

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded intangibles, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services, and realization of deferred tax assets.
Cash and Cash Equivalents	Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $ 250,000 Cash denominated in Euros with a US Dollar equivalent of $ 63,669 93,359 The Company has no customers that represent 10 The Company has no customers that accounted for greater than 10 Three Months Ended Six Months Ended 2017 2016 2017 2016 Vendor A 15 % 18 % 15 % 18 % Vendor B 12 % * 12 % * Vendor C 12 % * 12 % * * Less than 10%
Revenue Recognition	Revenue Recognition The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing two service offerings to our customers: annual licenses that allow customers to access and utilize certain premium features of our cloud based SaaS research intelligence platform (Platforms) and the transaction sale of STM content managed, sourced and delivered through the Platform (Transactions). Platforms We charge a subscription fee that allows customers to access and utilize certain premium features of our Platform. Revenue is recognized ratably over the term of the subscription agreement, which is typically one year, provided all other revenue recognition criteria have been met. Billings or payments received in advance of revenue recognition are recorded as deferred revenue. Transactions We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
Deferred Revenue	Deferred Revenue Customer deposits and billings or payments received in advance of revenue recognition are recorded as deferred revenue.
Cost of Revenue	Cost of Revenue Platforms Cost of Platform revenue consists primarily of personnel costs of our operations team, and to a lesser extent managed hosting providers and other third-party service and data providers. Transactions Cost of Transaction revenue consists primarily of the respective copyright fee for the permitted use of the content, less a discount in most cases, and to a much lesser extent, personnel costs of our operations team and third-party service providers.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (FASB) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
Foreign Currency	Foreign Currency The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to a gain of $ 485 12,872 63,669 93,359 Six Months Ended Year Ended 2017 2016 2017 2016 Period end Euro : US Dollar exchange rate 1.20 1.09 1.09 1.11 Average period Euro : US Dollar exchange rate 1.17 1.11 1.09 1.11 Period end Mexican Peso : US Dollar exchange rate 0.05 0.05 0.05 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05 0.05 0.06
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At December 31, 2017 potentially dilutive securities include options to acquire 3,185,435 1,985,000 3,122,277 1,985,000 Basic and diluted net loss per common share is the same for the three and six months ended December 31, 2017 and 2016 because all stock options, warrants, and unvested restricted common stock are anti-dilutive.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Summary of Significant Accoun14

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Schedule of Concentration of Risk	The following table summarizes vendor concentrations: Three Months Ended Six Months Ended 2017 2016 2017 2016 Vendor A 15 % 18 % 15 % 18 % Vendor B 12 % * 12 % * Vendor C 12 % * 12 % * * Less than 10%
Schedule Of Foreign Currency Exchange Rate	The following table summarizes the exchange rates used: Six Months Ended Year Ended 2017 2016 2017 2016 Period end Euro : US Dollar exchange rate 1.20 1.09 1.09 1.11 Average period Euro : US Dollar exchange rate 1.17 1.11 1.09 1.11 Period end Mexican Peso : US Dollar exchange rate 0.05 0.05 0.05 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05 0.05 0.06

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Dec. 31, 2017
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes vested and unvested stock option activity: All Options Vested Options Unvested Options Shares Weighted Shares Weighted Shares Weighted Outstanding at June 30, 2017 3,130,310 1.15 2,994,851 1.15 135,459 1.07 Granted 707,000 1.31 685,000 1.31 22,000 1.20 Options vesting - - 48,250 1.06 (48,250) 1.06 Exercised (175,000) 1.10 (175,000) 1.10 - - Forfeited/Cancelled (476,875) 1.31 (471,042) 1.32 (5,833) 1.09 Outstanding at December 31, 2017 3,185,435 $ 1.16 3,082,059 $ 1.16 103,376 $ 1.07
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The following table presents the assumptions used to estimate the fair values based upon a Black-Scholes option pricing model of the stock options granted during the six months ended December 31, 2017 and 2016. Six Months Ended 2017 2016 Expected dividend yield 0 % 0 % Risk-free interest rate 1.45% - 2.23 % 1.27% - 1.76 % Expected life (in years) 2.60 - 6.0 5 - 6 Expected volatility 75% - 76 % 79.2% - 81.4 %
Schedule of Share-based Compensation, by Exercise Price Range	Additional information regarding stock options outstanding and exercisable as of December 31, 2017 is as follows: Option Options Remaining Options $ 0.59 8,150 4.50 8,150 0.60 5,000 4.50 5,000 0.65 6,150 4.50 6,150 0.70 225,000 7.93 225,000 0.77 59,500 5.76 59,500 0.80 16,000 7.64 16,000 0.90 25,667 6.31 25,667 0.97 6,000 4.50 6,000 1.00 300,249 2.60 300,247 1.02 247,000 2.90 247,000 1.05 457,529 8.63 415,530 1.07 53,898 4.79 53,898 1.09 156,165 7.95 116,790 1.10 105,000 7.50 105,000 1.14 3,674 4.50 3,674 1.15 293,000 3.07 293,000 1.20 353,414 9.57 331,414 1.25 32,000 5.12 32,000 1.30 263,000 4.18 263,000 1.50 380,000 1.00 380,000 1.75 1,067 4.50 1,067 1.80 162,550 5.45 162,550 1.85 24,000 5.09 24,000 1.97 1,422 4.50 1,422 Total 3,185,435 3,082,059
Schedule of Other Share-based Compensation, Activity	The following table summarizes warrant activity: Number of Weighted Outstanding, June 30, 2017 1,985,000 1.25 Granted - - Exercised - - Expired/Cancelled - - Outstanding, December 31, 2017 1,985,000 $ 1.25 Exercisable, June 30, 2017 1,985,000 $ 1.25 Exercisable, December 31, 2017 1,985,000 $ 1.25
Schedule of Stockholders' Equity Note, Warrants or Rights	Additional information regarding warrants outstanding and exercisable as of December 31, 2017 is as follows: Warrant Warrants Remaining Warrants $ 1.19 100,000 3.98 100,000 1.25 1,885,000 3.45 1,885,000 Total 1,985,000 1,985,000
Schedule of Nonvested Restricted Stock Units Activity	The following table summarizes restricted common stock activity: Number of Fair Value Weighted Non-vested, June 30, 2017 513,194 412,938 0.92 Granted 338,302 354,366 1.05 Vested (193,336) (205,339) 0.90 Forfeited - - - Non-vested, December 31, 2017 658,160 $ 561,965 $ 0.99

Summary of Significant Accoun16

Summary of Significant Accounting Policies (Details)	3 Months Ended			6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016		Dec. 31, 2017	Dec. 31, 2016
Vendor A [Member]
Concentration Risk, Percentage	15.00%	18.00%		15.00%	18.00%
Vendor B [Member]
Concentration Risk, Percentage	12.00%		[1]	12.00%		[1]
Vendor C [Member]
Concentration Risk, Percentage	12.00%		[1]	12.00%		[1]
[1]	Less than 10%

Summary of Significant Accoun17

Summary of Significant Accounting Policies (Details 1)	6 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2017	Jun. 30, 2016
Euro to US Dollar [Member]
Period end exchange rate	1.2	1.09	1.09	1.11
Average period exchange rate	1.17	1.11	1.09	1.11
Mexican Peso to US Dollar [Member]
Period end exchange rate	0.05	0.05	0.05	0.05
Average period exchange rate	0.05	0.05	0.05	0.06

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2017
Cash, FDIC Insured Amount	$ 250,000		$ 250,000
Foreign Currency Transaction Gain (Loss), before Tax	$ 485	$ (17,631)	$ 12,872	$ (20,955)
Concentration Risk, Benchmark Description			Less than 10%
Sales Revenue, Net [Member]
Concentration Risk, Percentage	10.00%	10.00%	10.00%	10.00%
Accounts Receivable [Member]
Concentration Risk, Percentage			10.00%		10.00%
Europe Financial Institutions [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			63,669		93,359
Deposits	$ 63,669		$ 63,669		$ 93,359
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			3,185,435	3,122,277
Employee Stock Option [Member] | Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			1,985,000	1,985,000

Line of Credit (Details Textual

Line of Credit (Details Textual) - USD ($)	1 Months Ended	6 Months Ended
	Jul. 23, 2010	Dec. 31, 2017
Line of Credit Facility, Interest Rate Description		the prime rate plus 5.25%
Line of Credit Facility, Remaining Borrowing Capacity		$ 2,490,000
Line of Credit Facility, Interest Rate at Period End		6.75%
Minimum [Member]
Debt Instrument, Covenant Compliance		1
Maximum [Member]
Debt Instrument, Covenant Compliance		1.3
Silicon Valley Bank [Member]
Line of Credit Facility, Amount Outstanding	$ 2,500,000
Line Of Credit Facility Expiration Date 1		Dec. 31, 2019
Debt Instrument, Basis Spread on Variable Rate		2.25%
Debt Instrument, Covenant Description		Financial covenants include maintaining an adjusted quick ratio of unrestricted cash and net accounts receivable, divided by current liabilities plus debt less deferred revenue of at least 1.15 to 1.0, and maintaining tangible net worth of $1,500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2017, plus 50% of the dollar value of equity issuances after October 1, 2017 and the principal amount of subordinated debt.
Percentage Of Eligible Accounts Receivable On Line Of Credit	80.00%

Lease Obligations (Details Text

Lease Obligations (Details Textual) - USD ($)	6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2017
Operating Lease Liabilities, Fair Value	$ 463,000
Operating Lease Discount Rate	3.75%
Operating Leases, Rent Expense	$ 62,881	$ 32,564
Amortization of Leased Asset	54,759	$ 0
Operating Lease, Payments	54,000
Operating Lease, Liability	385,187		$ 439,187
Minimum [Member]
Operating Leases, Rent Expense, Minimum Rentals	10,350
Maximum [Member]
Operating Leases, Rent Expense, Minimum Rentals	$ 11,475

Stockholders' Equity (Details)

Stockholders' Equity (Details)	6 Months Ended
	Dec. 31, 2017$ / sharesshares
Outstanding beginning balance Shares | shares	3,130,310
Granted Shares | shares	707,000
Options vesting Shares | shares	0
Exercised Shares | shares	(175,000)
Forfeited/Cancelled Shares | shares	(476,875)
Outstanding ending balance Shares | shares	3,185,435
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.15
Granted Weighted Average Exercise Price | $ / shares	1.31
Options vesting Weighted Average Exercise Price | $ / shares	0
Exercised Weighted Average Exercise Price | $ / shares	1.1
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	1.31
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.16
Vested Options [Member]
Outstanding beginning balance Shares | shares	2,994,851
Granted Shares | shares	685,000
Options vesting Shares | shares	48,250
Exercised Shares | shares	(175,000)
Forfeited/Cancelled Shares | shares	(471,042)
Outstanding ending balance Shares | shares	3,082,059
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.15
Granted Weighted Average Exercise Price | $ / shares	1.31
Options vesting Weighted Average Exercise Price | $ / shares	1.06
Exercised Weighted Average Exercise Price | $ / shares	1.1
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	1.32
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.16
Unvested Options [Member]
Outstanding beginning balance Shares | shares	135,459
Granted Shares | shares	22,000
Options vesting Shares | shares	(48,250)
Exercised Shares | shares	0
Forfeited/Cancelled Shares | shares	(5,833)
Outstanding ending balance Shares | shares	103,376
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.07
Granted Weighted Average Exercise Price | $ / shares	1.2
Options vesting Weighted Average Exercise Price | $ / shares	1.06
Exercised Weighted Average Exercise Price | $ / shares	0
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	1.09
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.07

Stockholders' Equity (Details 1

Stockholders' Equity (Details 1)	6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Expected dividend yield	0.00%	0.00%
Maximum [Member]
Risk-free interest rate	2.23%	1.76%
Expected life (in years)	6 years	6 years
Expected volatility	76.00%	81.40%
Minimum [Member]
Risk-free interest rate	1.45%	1.27%
Expected life (in years)	2 years 7 months 6 days	5 years
Expected volatility	75.00%	79.20%

Stockholders' Equity (Details 2

Stockholders' Equity (Details 2)	6 Months Ended
	Dec. 31, 2017$ / sharesshares
Options Outstanding	3,185,435
Options Exercisable	3,082,059
Range One [Member]
Option Exercise Price | $ / shares	$ 0.59
Options Outstanding	8,150
Remaining Contractual Life (in years)	4 years 6 months
Options Exercisable	8,150
Range Two [Member]
Option Exercise Price | $ / shares	$ 0.60
Options Outstanding	5,000
Remaining Contractual Life (in years)	4 years 6 months
Options Exercisable	5,000
Range Three [Member]
Option Exercise Price | $ / shares	$ 0.65
Options Outstanding	6,150
Remaining Contractual Life (in years)	4 years 6 months
Options Exercisable	6,150
Range Four [Member]
Option Exercise Price | $ / shares	$ 0.70
Options Outstanding	225,000
Remaining Contractual Life (in years)	7 years 11 months 5 days
Options Exercisable	225,000
Range Five [Member]
Option Exercise Price | $ / shares	$ 0.77
Options Outstanding	59,500
Remaining Contractual Life (in years)	5 years 9 months 4 days
Options Exercisable	59,500
Range Six [Member]
Option Exercise Price | $ / shares	$ 0.80
Options Outstanding	16,000
Remaining Contractual Life (in years)	7 years 7 months 20 days
Options Exercisable	16,000
Range Seven [Member]
Option Exercise Price | $ / shares	$ 0.90
Options Outstanding	25,667
Remaining Contractual Life (in years)	6 years 3 months 22 days
Options Exercisable	25,667
Range Eight [Member]
Option Exercise Price | $ / shares	$ 0.97
Options Outstanding	6,000
Remaining Contractual Life (in years)	4 years 6 months
Options Exercisable	6,000
Range Nine [Member]
Option Exercise Price | $ / shares	$ 1
Options Outstanding	300,249
Remaining Contractual Life (in years)	2 years 7 months 6 days
Options Exercisable	300,247
Range Ten [Member]
Option Exercise Price | $ / shares	$ 1.02
Options Outstanding	247,000
Remaining Contractual Life (in years)	2 years 10 months 24 days
Options Exercisable	247,000
Range Eleven [Member]
Option Exercise Price | $ / shares	$ 1.05
Options Outstanding	457,529
Remaining Contractual Life (in years)	8 years 7 months 17 days
Options Exercisable	415,530
Range Twelve [Member]
Option Exercise Price | $ / shares	$ 1.07
Options Outstanding	53,898
Remaining Contractual Life (in years)	4 years 9 months 14 days
Options Exercisable	53,898
Range Thirteen [Member]
Option Exercise Price | $ / shares	$ 1.09
Options Outstanding	156,165
Remaining Contractual Life (in years)	7 years 11 months 12 days
Options Exercisable	116,790
Range Fourteen [Member]
Option Exercise Price | $ / shares	$ 1.10
Options Outstanding	105,000
Remaining Contractual Life (in years)	7 years 6 months
Options Exercisable	105,000
Range Fifteen [Member]
Option Exercise Price | $ / shares	$ 1.14
Options Outstanding	3,674
Remaining Contractual Life (in years)	4 years 6 months
Options Exercisable	3,674
Range Sixteen [Member]
Option Exercise Price | $ / shares	$ 1.15
Options Outstanding	293,000
Remaining Contractual Life (in years)	3 years 25 days
Options Exercisable	293,000
Range Seventeen [Member]
Option Exercise Price | $ / shares	$ 1.20
Options Outstanding	353,414
Remaining Contractual Life (in years)	9 years 6 months 25 days
Options Exercisable	331,414
Range Eighteen [Member]
Option Exercise Price | $ / shares	$ 1.25
Options Outstanding	32,000
Remaining Contractual Life (in years)	5 years 1 month 13 days
Options Exercisable	32,000
Range Nineteen [Member]
Option Exercise Price | $ / shares	$ 1.30
Options Outstanding	263,000
Remaining Contractual Life (in years)	4 years 2 months 5 days
Options Exercisable	263,000
Range Twenty [Member]
Option Exercise Price | $ / shares	$ 1.50
Options Outstanding	380,000
Remaining Contractual Life (in years)	1 year
Options Exercisable	380,000
Range Twenty One [Member]
Option Exercise Price | $ / shares	$ 1.75
Options Outstanding	1,067
Remaining Contractual Life (in years)	4 years 6 months
Options Exercisable	1,067
Range Twenty Two [Member]
Option Exercise Price | $ / shares	$ 1.80
Options Outstanding	162,550
Remaining Contractual Life (in years)	5 years 5 months 12 days
Options Exercisable	162,550
Range Twenty Three [Member]
Option Exercise Price | $ / shares	$ 1.85
Options Outstanding	24,000
Remaining Contractual Life (in years)	5 years 1 month 2 days
Options Exercisable	24,000
Range Twenty Four [Member]
Option Exercise Price | $ / shares	$ 1.97
Options Outstanding	1,422
Remaining Contractual Life (in years)	4 years 6 months
Options Exercisable	1,422

Stockholders' Equity (Details 3

Stockholders' Equity (Details 3) - $ / shares	6 Months Ended
	Dec. 31, 2017	Jun. 30, 2017
Non-vested, Ending balance	1,985,000
Exercisable Number of Warrants	1,985,000
Warrant [Member]
Non-vested, Beginning balance	1,985,000
Granted Number of Warrants	0
Exercised Number of Warrants	0
Expired/Cancelled Number of Warrants	0
Non-vested, Ending balance	1,985,000
Exercisable Number of Warrants	1,985,000	1,985,000
Outstanding, Beginning balance Weighted Average Exercise Price	$ 1.25
Granted Weighted Average Exercise Price	0
Exercised Weighted Average Exercise Price	0
Expired/Cancelled Weighted Average Expired Price	0
Outstanding, Ending balance Weighted Average Exercise Price	1.25
Exercisable, Weighted Average Exercise Price	$ 1.25	$ 1.25

Stockholders' Equity (Details 4

Stockholders' Equity (Details 4)	6 Months Ended
	Dec. 31, 2017$ / sharesshares
Warrants Outstanding	1,985,000
Warrants Exercisable	1,985,000
Range One [Member]
Warrant Exercise Price | $ / shares	$ 1.19
Warrants Outstanding	100,000
Warrants Outstanding Remaining Contractual Life (in years)	3 years 11 months 23 days
Warrants Exercisable	100,000
Range Two [Member]
Warrant Exercise Price | $ / shares	$ 1.25
Warrants Outstanding	1,885,000
Warrants Outstanding Remaining Contractual Life (in years)	3 years 5 months 12 days
Warrants Exercisable	1,885,000

Stockholders' Equity (Details 5

Stockholders' Equity (Details 5)	6 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares
Non-vested, Ending balance	1,985,000
Restricted Common Stock [Member]
Non-vested, Beginning balance	513,194
Granted Number of shares	338,302
Vested, Number of shares	(193,336)
Forfeited, Number of shares	0
Non-vested, Ending balance	658,160
Non-vested, Beginning balance | $	$ 412,938
Granted, Fair Value | $	354,366
Vested, Fair Value | $	(205,339)
Forfeited, Fair Value | $	0
Non-vested, Ending balance | $	$ 561,965
Non-vested, Beginning Balance Weighted Average Grant Date Fair Value | $ / shares	$ 0.92
Granted Weighted Average Grant Date Fair Value | $ / shares	1.05
Vested Weighted Average Grant Date Fair Value | $ / shares	0.9
Forfeited Weighted Average Grant Date Fair Value | $ / shares	0
Non-vested,Ending Balance Weighted Average Grant Date Fair Value | $ / shares	$ 0.99

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2017	Nov. 21, 2017	Nov. 10, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,592,130			1,874,513
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	6 years 14 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	5 years 11 months 23 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 434,042
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	421,343
Stock or Unit Option Plan Expense	6,233	$ 0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	68,175
Stock Issued During Period, Value, Restricted Stock Award, Gross	205,339
Stock Repurchase Program, Authorized Amount	$ 17,600
Stock Repurchased During Period, Shares	87,100
Stock Repurchased During Period, Value	$ 102,955
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	707,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 389,236
Proceeds from Stock Options Exercised	$ 389,236	$ 228,491
Stock Repurchased Average Price Per Share	$ 1.18
Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)	175,000
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	13,235
Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	707,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 383,890
Restricted Stock [Member]
Stock or Unit Option Plan Expense			$ 1,150,136
Stock Issued During Period, Shares, Restricted Stock Award, Gross	338,302		1,573,197
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 354,366		$ 1,563,074
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options	$ 561,965
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					5,000,000
Sale of Stock, Price Per Share	$ 1.02
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					7,000,000
Sale of Stock, Price Per Share	$ 1.20

Gain from Sale of Discontinue28

Gain from Sale of Discontinued Operations (Reprints and ePrints business line) (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax		$ 79,353	$ 0	$ 136,502	$ 0
Reprints and ePrints business line [Member]
Earn-out Income Percentage On Sale Of Intangible Assets	45.00%
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax				$ 136,502